6月23日周一盘前，Hims & Hers Health Inc.（股票代码：HIMS）股价大幅下跌18.56%，引发市场广泛关注。此次暴跌主要源于一则重磅消息：全球知名制药巨头诺和诺德（Novo Nordisk）宣布终止与Hims & Hers Health的合作关系。
据悉，诺和诺德此举对Hims & Hers Health的业务发展造成了重大打击。作为一家专注于提供远程医疗服务和个人护理产品的公司，Hims & Hers Health与诺和诺德的合作一直被视为其业务拓展的重要支撑。这一合作关系的终止不仅可能影响公司的产品线，还可能对其在医疗保健领域的市场地位产生负面影响。
值得注意的是，早期报道显示Hims & Hers Health股价仅下跌7.5%，但实际跌幅达到了18.56%。这一差异表明，随着更多投资者消化这一消息，市场对该公司前景的担忧程度进一步加深。分析人士指出，投资者可能需要密切关注公司后续的战略调整和可能的新合作伙伴，以评估其长期发展潜力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.